Willow vs Noom for GLP-1 Medications: Why Willow Wins? 2026

5/5 - (9 votes)

As demand for GLP-1 weight loss medications continues to rise, two major platforms have entered the spotlight: Willow and Noom. While both offer access to Semaglutide and Tirzepatide, their programs differ dramatically in cost, accessibility, structure, and overall value. After comparing their features, pricing, and patient experience, Willow stands out as the superior choice for most people seeking affordable and convenient GLP-1 treatment in 2025.

Check Willow Pricing

Overview: Willow vs Noom

Both Willow and Noom provide pathways to GLP-1 medications such as Semaglutide and Tirzepatide. However, their models differ significantly. Willow is a medication-first telehealth provider focused on affordability, speed, and simplicity. Noom is a behavior-change coaching platform that added GLP-1 medications through Noom Med, but at a significantly higher cost due to mandatory coaching and program fees.

Why Willow Wins when comparing Willow vs Noom?

Willow offers the fastest and most affordable pathway to GLP-1 medications without forcing users into expensive add-on programs. The company focuses solely on medical weight management, resulting in a smoother, simpler, and more cost-effective experience.

What Makes Willow Superior

Lower monthly pricing than Noom
No mandatory coaching or upsells
Quick online intake and provider evaluation
Transparent monthly billing with no hidden fees
Compounded Semaglutide and Tirzepatide directly shipped to your door

Start Your Willow Intake

Noom: Coaching Program First, Medication Second

Noom is widely known for its coaching-based model and psychology-driven app. When they added GLP-1 access, they integrated it into their existing habit-based program. This means you cannot access medication through Noom without also paying for coaching, tracking tools, and curriculum-based guidance. While these features may benefit some users, they dramatically increase the monthly cost compared to Willow.

Noom’s Key Limitations

Higher program cost due to mandatory coaching
More steps and longer onboarding timeline
Medication availability varies by region
Not intended for users who want a medication-focused program

Pricing Comparison

Pricing is one of the most significant differences between Willow vs Noom. Willow’s medication-only structure keeps costs low, while Noom bundles coaching and curriculum into every plan.

Category	Willow	Noom
Semaglutide (Compounded)	Lower cost	Higher due to program bundle
Tirzepatide (Compounded)	Affordable monthly pricing	More expensive, coaching included
Coaching Included	No	Yes, mandatory
Labs Required	No	Sometimes required

View Willow Plans

Medication Availability

Medication	Willow	Noom
Semaglutide (Compounded) (Injectables & Sublingual Tablets)	Yes	Yes
Tirzepatide (Compounded)	Yes	Limited
Wegovy	No	Yes (availability varies)
Zepbound	No	Yes (availability varies)

Which Platform Is Better for You? (Willow vs Noom)

Choose Willow If You Want:

Fast approval process
Affordable GLP-1 treatment without expensive extras
A simple, medication-first approach
Predictable monthly costs

Choose Noom If You Want:

Medication plus habit coaching
A curriculum-based system for long-term behavior change
Brand-name GLP-1 options (depending on region)

Final Verdict: Willow Is the Better Choice for GLP-1 Medications

For most people seeking effective and affordable GLP-1 therapy in 2025, Willow is the clear winner. Its lower pricing, simple intake, faster approvals, and medication-focused approach make it more accessible and efficient than Noom’s bundled, coaching-heavy model. While Noom may appeal to those who want intensive behavior coaching, Willow delivers the best overall value for GLP-1 medication access.

Start GLP-1 Treatment With Willow

⭐ Editor’s Choice